NPPB and hydrops fetalis: In a sub-analysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF), baseline ET-1 correlated with adverse events during hospitalization and 3-month death in patients hospitalized for acute HF, with an additive prognostic value over NT-proBNP [71].